|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:REL-MAN1A2 (FusionGDB2 ID:HG5966TG10905) |
Fusion Gene Summary for REL-MAN1A2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: REL-MAN1A2 | Fusion gene ID: hg5966tg10905 | Hgene | Tgene | Gene symbol | REL | MAN1A2 | Gene ID | 5966 | 10905 |
Gene name | REL proto-oncogene, NF-kB subunit | mannosidase alpha class 1A member 2 | |
Synonyms | C-Rel | MAN1B | |
Cytomap | ('REL')('MAN1A2') 2p16.1 | 1p12 | |
Type of gene | protein-coding | protein-coding | |
Description | proto-oncogene c-Reloncogene REL, avian reticuloendotheliosisv-rel avian reticuloendotheliosis viral oncogene homolog | mannosyl-oligosaccharide 1,2-alpha-mannosidase IBalpha-1,2-mannosidase IBalpha1,2-mannosidaseprocessing alpha-1,2-mannosidase IB | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000295025, ENST00000394479, | ||
Fusion gene scores | * DoF score | 5 X 6 X 4=120 | 12 X 8 X 6=576 |
# samples | 7 | 15 | |
** MAII score | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/576*10)=-1.94110631094643 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: REL [Title/Abstract] AND MAN1A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | REL(61147777)-MAN1A2(118035769), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | REL-MAN1A2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. REL-MAN1A2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | REL | GO:0010629 | negative regulation of gene expression | 22065573 |
Hgene | REL | GO:0032688 | negative regulation of interferon-beta production | 22065573 |
Hgene | REL | GO:0045944 | positive regulation of transcription by RNA polymerase II | 1406630 |
Fusion gene breakpoints across REL (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across MAN1A2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-60-2726-01A | REL | chr2 | 61147777 | - | MAN1A2 | chr1 | 118035769 | + |
ChimerDB4 | LUSC | TCGA-60-2726-01A | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + |
ChimerDB4 | LUSC | TCGA-60-2726 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + |
Top |
Fusion Gene ORF analysis for REL-MAN1A2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000295025 | ENST00000482811 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + |
5CDS-intron | ENST00000394479 | ENST00000482811 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + |
In-frame | ENST00000295025 | ENST00000356554 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + |
In-frame | ENST00000394479 | ENST00000356554 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000295025 | REL | chr2 | 61147777 | + | ENST00000356554 | MAN1A2 | chr1 | 118035769 | + | 8080 | 1407 | 254 | 2164 | 636 |
ENST00000394479 | REL | chr2 | 61147777 | + | ENST00000356554 | MAN1A2 | chr1 | 118035769 | + | 7849 | 1176 | 119 | 1933 | 604 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000295025 | ENST00000356554 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + | 0.000178394 | 0.9998216 |
ENST00000394479 | ENST00000356554 | REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035769 | + | 0.00016197 | 0.999838 |
Top |
Fusion Genomic Features for REL-MAN1A2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035768 | + | 8.42E-06 | 0.99999154 |
REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035768 | + | 8.42E-06 | 0.99999154 |
REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035768 | + | 8.42E-06 | 0.99999154 |
REL | chr2 | 61147777 | + | MAN1A2 | chr1 | 118035768 | + | 8.42E-06 | 0.99999154 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for REL-MAN1A2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:61147777/chr1:118035769) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | REL | chr2:61147777 | chr1:118035769 | ENST00000295025 | + | 10 | 11 | 8_297 | 362 | 620.0 | Domain | RHD |
Hgene | REL | chr2:61147777 | chr1:118035769 | ENST00000295025 | + | 10 | 11 | 290_295 | 362 | 620.0 | Motif | Nuclear localization signal |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | MAN1A2 | chr2:61147777 | chr1:118035769 | ENST00000356554 | 7 | 13 | 2_36 | 389 | 642.0 | Topological domain | Cytoplasmic | |
Tgene | MAN1A2 | chr2:61147777 | chr1:118035769 | ENST00000356554 | 7 | 13 | 58_641 | 389 | 642.0 | Topological domain | Lumenal | |
Tgene | MAN1A2 | chr2:61147777 | chr1:118035769 | ENST00000356554 | 7 | 13 | 37_57 | 389 | 642.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Top |
Fusion Gene Sequence for REL-MAN1A2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>73447_73447_1_REL-MAN1A2_REL_chr2_61147777_ENST00000295025_MAN1A2_chr1_118035769_ENST00000356554_length(transcript)=8080nt_BP=1407nt AGCCGCGGGAAATTCCCCTCCCGCCAGGCTGCTCGCCTCTCGGCTGGGCCAGCACTCGGCTCTCCCCGCTCCGCCCCCTGCCCCTGGCTC CCGTACGGTGGACGGCGACGCTGGGTGACCCGGGGTGCAAGAATTCAGGGGTTGGGAAGGTGTGAGCCGCAAACCCAGCGGAGGGCGGGA AGAAGGAGGAGGCCTCTAGGGTGGTCGGGGGACTGGGGGCCCCGCCGGCAGAGGTCCCTCGGCCTCCTGACTGACTGACTGCGGCCGCCT CCGGCCAGGACGCTGGGAGCTGCCTGCGGGAAGGTGCGGGGAGCGGAGCCATGGCCTCCGGTGCGTATAACCCGTATATAGAGATAATTG AACAACCCAGGCAGAGGGGAATGCGTTTTAGATACAAATGTGAAGGGCGATCAGCAGGCAGCATTCCAGGGGAGCACAGCACAGACAACA ACCGAACATACCCTTCTATCCAGATTATGAACTATTATGGAAAAGGAAAAGTGAGAATTACATTAGTAACAAAGAATGACCCATATAAAC CTCATCCTCATGATTTAGTTGGAAAAGACTGCAGAGACGGCTACTATGAAGCAGAATTTGGACAAGAACGCAGACCTTTGTTTTTCCAAA ATTTGGGTATTCGATGTGTGAAGAAAAAAGAAGTAAAAGAAGCTATTATTACAAGAATAAAGGCAGGAATCAATCCATTCAATGTCCCTG AAAAACAGCTGAATGATATTGAAGATTGTGACCTCAATGTGGTGAGACTGTGTTTTCAAGTTTTTCTCCCTGATGAACATGGTAATTTGA CGACTGCTCTTCCTCCTGTTGTCTCGAACCCAATTTATGACAACCGTGCTCCAAATACTGCAGAATTAAGGATTTGTCGTGTAAACAAGA ATTGTGGAAGTGTCAGAGGAGGAGATGAAATATTTCTACTTTGTGACAAAGTTCAGAAAGATGACATAGAAGTTCGTTTTGTGTTGAACG ATTGGGAAGCAAAAGGCATCTTTTCACAAGCTGATGTACACCGTCAAGTAGCCATTGTTTTCAAAACTCCACCATATTGCAAAGCTATCA CAGAACCCGTAACAGTAAAAATGCAGTTGCGGAGACCTTCTGACCAGGAAGTTAGTGAATCTATGGATTTTAGATATCTGCCAGATGAAA AAGATACTTACGGCAATAAAGCAAAGAAACAAAAGACAACTCTGCTTTTCCAGAAACTGTGCCAGGATCACGTAGAAACAGGGTTTCGCC ATGTTGACCAGGATGGTCTTGAACTCCTGACATCAGGTGATCCACCCACCTTGGCCTCCCAAAGTGCTGGGATTACAGTTAATTTTCCTG AGAGACCAAGACCTGGTCTCCTCGGTTCAATTGGAGAAGGAAGATACTTCAAAAAAGATCATACATCTGTCGGTGGCCTGGGAGACAGTT TTTATGAATACTTACTGAAAGCATGGTTGATGTCAGATAAAACAGACCATGAGGCAAGAAAGATGTATGATGATGCTATTGAGGCTATAG AAAAACATCTTATTAAGAAGTCTCGTGGAGGTCTTACCTTTATTGGAGAATGGAAGAATGGGCACTTGGAAAAAAAGATGGGGCATTTGG CCTGCTTTGCTGGGGGAATGTTTGCACTAGGAGCAGATGGTTCCAGAGCAGATAAAGCTGGTCATTATTTAGAGCTAGGGGCAGAAATTG CACGTACTTGTCATGAGTCATATGACAGAACTGCATTAAAGCTAGGTCCTGAATCATTCAAGTTTGATGGTGCAGTGGAGGCTGTGGCTG TCCGGCAGGCTGAAAAGTATTATATCCTCCGTCCAGAAGTAATTGAAACCTATTGGTACCTATGGCGATTCACTCACGATCCAAGATACA GGCAGTGGGGCTGGGAAGCAGCACTGGCCATTGAAAAGTATTGCCGAGTTAATGGTGGGTTTTCTGGAGTCAAAGATGTATATTCCTCTA CTCCTACACATGATGATGTACAGCAGAGCTTTTTTCTTGCTGAAACATTAAAATATTTGTATCTGCTGTTCTCCGGTGATGACCTTTTAC CTTTAGACCACTGGGTGTTTAATACAGAGGCTCACCCTCTGCCTGTGTTACATTTAGCCAACACCACACTTTCAGGTAATCCTGCTGTTC GATGAAAGCAGTTCCAGAAGGACCATTCTCACCTGTGTTTTGTTTACATGGACCACTACAGAAATTAGTTTGAAGGGGCGGCTTTTGAAA ACCTGGACCTCTATGTCAACATGACAGGGTGAAACTATTCCCCCTAAGACTGTTCAACTTGTAGATACATCAACTTTGAAATTATTCCAT TTTATACCTGACCAAAACATGTTCTGATATGTGTAGGACAGAGACCTGGATGTGCTTTGATCGTTAATGAGGTGGTCACATGAGAAATGA TACCTGTTACTACTGTATTGTTTTTAGAGTCCTGAAGTCTGGAGGCTAGACTTCCTGAAAGCAAGTCAAGAATATAGAGCACCTTGCAGG AGTTCAAGATGGCCTTTGGAACCAATTATGTATTTGTTTCCTCCTACAGTGGAGCAGCATTCAAATCAAATATTTACATATTGCTTATCA CTTTTTCTCCATTTTAATAATGGAATGAACTAAAATAAACAAGAACAAAAGAATAGTATAATTATATCAGTAACAAGAAGACTCAAAAAA GAAACAGGAGTACCTATCCCTATCTGAATTTTCAAGTTCCCCATTGGATGACCAGACTGGCAACCATTTCAAATCCCAGTCTATTTCATT GAAATTTCTTGGTTAAGTTTAATTTTCTCTGGGGGCATGATCTCACAAAGAATACTCAAGTCTTTTTCTTCTTATGGAATCATCGAAACT GCTATTTATCATAATCACCACTTATGAGCCTGGGTTTGGGATTTTGTGCATGTAGTTCAGTCTAGTGTTGGTAGCATGACAGAAAGTGGG GAAAATGCCGCAGTTTGTTGCCTTGAAACCTAAGAGCAATCCTTGGTTTTGTTGCTACATTATTTTTCCAGACCAACACATCTACCAAGT AAATTTTATTCACTTTAATTTCATAATAAAGTTAGTAGAGTCACTCAACTTACAACTTTATTTATGTGGCTTGGCAAAAATCACTATAAG GCAGCTCTAAATTTGCCTTGATAAGCTAAATAAATTACTTTTATAACTTACTAAAGCAGAACAAACAGTGAAACTTTCTAAAATATTCTA TCTGGAATAGGGACAGGGGATCTTTTATTTATAATCTCATCAGATGAGTGAGTTGTTCACAGATATTTTATGTTTTTTTAATTTTCTCCA AGAATATTTATAGAATTCCAAAGAATCAGAATAGTTTCAAAATAATTTTCAGTGATAAAAGAGTGTTGTAATTAATCATATTACACTAAA ATTGGGATACATCTAAGGAACTTTATCTTACTATCAGTAGGTTTTGCATTGATATTTCTTTTTAAATAAACTACTAGTTCTTTATATTTT GACAAAAAGAACTTAAATTTTATCAGGAACTGTAAGATAAATATCTAGTGCTTATAAATTTTCTGTCCTTAAATTTATGTGACAGTGCAA GATACTTTTGCTCTTTTCATTTAATATAGGCATCTTCCATTGACATTAATAAAACTTAGAAACAGTATAATTAGTATAACATTTACTCTG AATTTGAAGATTTCCTGAAACAAAGTTTGTACAAGAAGCCCACCTTGGAATTCTGAAGGCTTATTTTCTTGTTTGATAAGCTTTTCTTTT AAACTTAGGTTTTAAGTTGGGGAAAGACTTAATTAACTAATATAGTATTTTCTAAGGTTGATCATCTTATACCACGAATCGTTAATTTTG ACAGTTCTACTGATCCGTAAATGATAACCACTGCAAATTTTTTCAGTATAAAATTTTTCACTGCAAAAAAATTTCAGTAGAAAATAAGGA TGCAGGGCCAGTTACAATAGTCCTTAAGAGAGTTAAATTATAGCACATGTTTTGACATTGTAATATCTTTTACTACTTGAACATTTAAAT TTCTAAATGAGAAAGGTATATATATTACTGTAACTGTAGAAGGGAAAAGGGAAAGTATTTGGTTCTAAAAAATGTTAGCCTTCCTCGTAA AAGTAGCACAAGCCCACTTATGAATCACTGAGAAAAAGTGAAAAACTTGAGTTGGCAAAGATGCAGAGCAGCAGTGCAGATGGCAATGAA CTCTCTGAATTCTCTTTTACCTTATTTAGAAGAATGCAGAGTAAAGGGACCTTCTTGGTTCTGCAGGAACTTCTCAAGGGATGAGGAGAC AGAACCCCTACTTCCAAGTGCTCTATTTGTATTACCCAGATGACTGAAGCTTAAGAGAAGGCAGGGAAGTATACAAGCAGAGCCAGTTCT GGTACAAACAAAGAATTTGACAGGGACAATGGAAGGGTCTTCTTCACCACTCCTTACCTTCTATGTGATGGAAAGACTAGAGCTTATAAA AGTACTTCCATTTTTTTATTCTCCTGAATACCAAAGGCAATTAAAGTCAGCTACAAATGACTTGCCAGTGTCATGTTTTATTTTTGTTAT AGATTTTTAAATTATTTCCTTCAAGATCAATTCTTATCCCATATAATGCTTAGCTTCCAAGAATATTCTTTACTTTCTTCTGTCTTTTAC AGCTCTTTGCATTTTGTAGACCTTAATACTCAGGTTAAATATTCATTGCATTTATAAGATCTTCTGCAAAAAGCCCAGAAATGGTCCTTT TCAGGTGCCTCTTCAAAGAGCTGACACCTTACCTTGTGCCTTTGGCACAAATGTGCAGAATAGATACATCAGTTGGTGCATAATCGAAAA AAATAGGAATTTTGAACACTGTTCTTCCTTCTACATTTATTTCTCTTCATTTTAGAATCACACTTTTTATGTTAAACCAGATTATTATTA TTATTATTATTCAACCAGTATTAAGTTGTTAAAACCAAGGGAATGGGGCCCTAACCAAAAAGAAGTCTCAACTCAGAAAAATAAGTCCCC AGTCAGGTGGTTCTTACTTTCTTGTGGGTTGCACATTTTGTATCTCTCTAACATCAGCGTATTCCTGACTTTAAGCAGGTGTTTATATGT AAAATAAAACCTGGGTATCGAAGGGAAATGCATTCTTTTTATGGAGTATTGACCCTGATCCTCTATGATGTCATATAGAGCAACTCAGGG CTATACTTGCTAGATTTTAACCAAGCAGTTTGAAATATTAATCATCATCCTCTCATCTTCTCCACTCTCCATTGCCAAAGTCTTTGTCAA AACTCCAAATTTGTTGATAAAAGATTGTGTTTGCCATTCTCATTTATAATGCAGTTTCTCCTTAAGCCTGGAGTTTTTTGAATGAGTGCA TGAGTAAATGAGAGAATGTGTGAACGAACATTTATGAAGTATCTAACATGTGCCAAGCATTGTGCCTGGCACTTTCAATCATTAGAATGT TTTATGTGATTCCACAGCATTTTCTGTATGAGAGTAGCTCACAACATTTTAAATGTTTCCAATATGAATCGTGTTACAAAATTCTTAATT TTATATTTCATATAAATTAAAGAGGAAAAAGAAAAGGTTTATAATATATTTTAAAACAATGTGTTACTGTATAATACAACTATAATTGTA GTTAATAACTAAAACCTCTTGAAAATGTCAAAGAAATACTTGATTTCTGATGCAACTTTGACTAAAATATTTACTTTAGAAATAAAAACG TTCTTATTTTGCTATATCACTTTAATTGCATAATTAAAAAGCAGTGTTTTATAGAAATGCTGGTTATTTTATATTCAAAAAGATTTTGTC ACATAATTCATGGGTAAAACTTGCAGTTGTAAATTGTGTCTGCTCTGGTATGGGCCCTATTAATAGTCCCATGCTGTTAAATATAAAGAA AAATATACTAAAATATTCAAAGTTCCAAATAACAGTTCCTAGTAATAGTATTTTGAGTTATTTTTCTTTAGGTTTCCTTATACTCAAATT GGCTAGGTCCTATCTTTTCCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTATATATATATATATATATATATATATATGAG AGATATATGAGATATATGAGAGATCAAGATCTATATATGTATATAAATACAATTATACACAGATAATTTTTAATACTCTTTGTTAACAAA CACAGTTGAAAACTGGTTTCGGCTGCACAAATAAGCAGAATATTTGAGTAACTATATATGATATGGAGATATTTTAATCCATTTATCCTG GCTCAAGAACACTGATAAAGATGATTTTCTGTTACTTTAGCTCATTCAGATCAGGATGGACATGCTCTTTTTGATCTATAACTGTTCAGC CAGCTTCCAGATAATATTTTAGGCTATGAGAGCTATACAGTCTCTCTTATTACTCATTTCTGCTGTTGAAGTATCGAAAACAGATAGAGA TACTATGTAAAGAATGGGCGTAGCTATGTTCCAGGAAAACTTTATTTACAAAAGCAGATGGAGGGCTGGATTTGGTCCATGGGTCATAGT TAGTGACCCTGATCCCAAGTTTATTTTGTGTTAGACCCTCTAACCTTTGATCTGCGTCTTTTCTGTTTTGATTTACATAATTCATTTTTA AATCAAAAAGATGTGCGTATATATGGTTGTGTGTATCTGTATAACCTAAAGCTATAATATTTTGTTGTCTTGAAAGCAGATACACTCTTC CTGGAGTCTGTTCAGGTTTCAGGACGATTGACTATAATGAAAGAGACAGAATAGGGTAAGGGAAGATGGGTATGCTATCAGCCATTTTCT TTGCCTTGTCATTTAATGCCATAATTTCAGATTCTCTATGTAAAAAGAAGGTCTGTGTATTGTCAAAATAATATACTCTCCAAGTTCTCC TGCTCATTGACCCTTGAACCAGGATTCTGGATTGCTAGAGCTGCAGAAATTCACCCACTTGGGTACTCTTAGAGCTCTACAGCAAGAATA TGATAGAATGTCTGATCTTTGTGCTGCAGAAAGCAAACTTTTGAAGAATTCTAAGCAACAGAAAATGGGTTATGTGACTCATCTGCTATT TGGCAGCCACTATTCCTTTTTTAGACTGCAGAACGGTACTGCCCCTGTTACCTCTAGAATAGCCTGAGTCTGAGGAGTGCAGAGAAAAGA TATATCCAAAAGGAGAATCCCTTTCTCTTGCATAACTCTCAATCCTTTACAAGTAAGTAGCATTATTTCAGAATGTCTATATGCATCATT TTCAACTAAAGCATACCTCATCCTTAAACTTCCACTATTTAACAGCTAATCCATTTCAAACTTGGTTTGAGCCTAGCAATTGCAGAACTC ATAAAATTGCTTGTGAAATTACACACCATATTACTAGCATATACATTGCAGTGCTCCAATCATGCTAACAGATAATAGATTTTTCTTTAA GAATTTTATCAAATATTTCACTATTTGGGGAAATTTTAGAGGAGGGGAAGCCTGTATTCAGGATGATAGAGGGAGCAGAGACTTACTGTC TCTCTTCCACATTATAAATGAACTGCCTTTCCAGGTCCAACATGCTGTCAGGTTGCTTCAGCTCGGTGTGAATGTAAGTGTGGGGATCAA ACACACACACCTATACACATACATATTAATATGCAGAGGATTTTAAATAATTGCAAATGTCTTGTGGCTGTTTTATTTCTACAAAATTCT GTAAGATGTATACCAGAAAACATAATAAAGATAAGCTCAGTTCTTCATTGGGAAAAAATATTTTTAAAGAAAATTTAGAAGTTTTTGCTG AATTAAAGTATCTTCAATTTTAATTACTGGATTTGGAAGTTGAAATGCCATCCTTCAATATCACTGGTCTCAAATTCATTGATAGAATTT TTTCTTAAACTAATAAGTGGGGTAAGTATAATCTCCTAAATTGGTACCCACTGGCTGCTCCTAAACTGGTTTCCAGTCATGTCCTCCAGT >73447_73447_1_REL-MAN1A2_REL_chr2_61147777_ENST00000295025_MAN1A2_chr1_118035769_ENST00000356554_length(amino acids)=636AA_BP=330 MTAAASGQDAGSCLREGAGSGAMASGAYNPYIEIIEQPRQRGMRFRYKCEGRSAGSIPGEHSTDNNRTYPSIQIMNYYGKGKVRITLVTK NDPYKPHPHDLVGKDCRDGYYEAEFGQERRPLFFQNLGIRCVKKKEVKEAIITRIKAGINPFNVPEKQLNDIEDCDLNVVRLCFQVFLPD EHGNLTTALPPVVSNPIYDNRAPNTAELRICRVNKNCGSVRGGDEIFLLCDKVQKDDIEVRFVLNDWEAKGIFSQADVHRQVAIVFKTPP YCKAITEPVTVKMQLRRPSDQEVSESMDFRYLPDEKDTYGNKAKKQKTTLLFQKLCQDHVETGFRHVDQDGLELLTSGDPPTLASQSAGI TVNFPERPRPGLLGSIGEGRYFKKDHTSVGGLGDSFYEYLLKAWLMSDKTDHEARKMYDDAIEAIEKHLIKKSRGGLTFIGEWKNGHLEK KMGHLACFAGGMFALGADGSRADKAGHYLELGAEIARTCHESYDRTALKLGPESFKFDGAVEAVAVRQAEKYYILRPEVIETYWYLWRFT HDPRYRQWGWEAALAIEKYCRVNGGFSGVKDVYSSTPTHDDVQQSFFLAETLKYLYLLFSGDDLLPLDHWVFNTEAHPLPVLHLANTTLS -------------------------------------------------------------- >73447_73447_2_REL-MAN1A2_REL_chr2_61147777_ENST00000394479_MAN1A2_chr1_118035769_ENST00000356554_length(transcript)=7849nt_BP=1176nt CAGGGGTTGGGAAGGTGTGAGCCGCAAACCCAGCGGAGGGCGGGAAGAAGGAGGAGGCCTCTAGGGTGGTCGGGGGACTGGGGGCCCCGC CGGCAGAGGTCCCTCGGCCTCCTGACTGACTGACTGCGGCCGCCTCCGGCCAGGACGCTGGGAGCTGCCTGCGGGAAGGTGCGGGGAGCG GAGCCATGGCCTCCGGTGCGTATAACCCGTATATAGAGATAATTGAACAACCCAGGCAGAGGGGAATGCGTTTTAGATACAAATGTGAAG GGCGATCAGCAGGCAGCATTCCAGGGGAGCACAGCACAGACAACAACCGAACATACCCTTCTATCCAGATTATGAACTATTATGGAAAAG GAAAAGTGAGAATTACATTAGTAACAAAGAATGACCCATATAAACCTCATCCTCATGATTTAGTTGGAAAAGACTGCAGAGACGGCTACT ATGAAGCAGAATTTGGACAAGAACGCAGACCTTTGTTTTTCCAAAATTTGGGTATTCGATGTGTGAAGAAAAAAGAAGTAAAAGAAGCTA TTATTACAAGAATAAAGGCAGGAATCAATCCATTCAATGTCCCTGAAAAACAGCTGAATGATATTGAAGATTGTGACCTCAATGTGGTGA GACTGTGTTTTCAAGTTTTTCTCCCTGATGAACATGGTAATTTGACGACTGCTCTTCCTCCTGTTGTCTCGAACCCAATTTATGACAACC GTGCTCCAAATACTGCAGAATTAAGGATTTGTCGTGTAAACAAGAATTGTGGAAGTGTCAGAGGAGGAGATGAAATATTTCTACTTTGTG ACAAAGTTCAGAAAGATGACATAGAAGTTCGTTTTGTGTTGAACGATTGGGAAGCAAAAGGCATCTTTTCACAAGCTGATGTACACCGTC AAGTAGCCATTGTTTTCAAAACTCCACCATATTGCAAAGCTATCACAGAACCCGTAACAGTAAAAATGCAGTTGCGGAGACCTTCTGACC AGGAAGTTAGTGAATCTATGGATTTTAGATATCTGCCAGATGAAAAAGATACTTACGGCAATAAAGCAAAGAAACAAAAGACAACTCTGC TTTTCCAGAAACTGTGCCAGGATCACGTTAATTTTCCTGAGAGACCAAGACCTGGTCTCCTCGGTTCAATTGGAGAAGGAAGATACTTCA AAAAAGATCATACATCTGTCGGTGGCCTGGGAGACAGTTTTTATGAATACTTACTGAAAGCATGGTTGATGTCAGATAAAACAGACCATG AGGCAAGAAAGATGTATGATGATGCTATTGAGGCTATAGAAAAACATCTTATTAAGAAGTCTCGTGGAGGTCTTACCTTTATTGGAGAAT GGAAGAATGGGCACTTGGAAAAAAAGATGGGGCATTTGGCCTGCTTTGCTGGGGGAATGTTTGCACTAGGAGCAGATGGTTCCAGAGCAG ATAAAGCTGGTCATTATTTAGAGCTAGGGGCAGAAATTGCACGTACTTGTCATGAGTCATATGACAGAACTGCATTAAAGCTAGGTCCTG AATCATTCAAGTTTGATGGTGCAGTGGAGGCTGTGGCTGTCCGGCAGGCTGAAAAGTATTATATCCTCCGTCCAGAAGTAATTGAAACCT ATTGGTACCTATGGCGATTCACTCACGATCCAAGATACAGGCAGTGGGGCTGGGAAGCAGCACTGGCCATTGAAAAGTATTGCCGAGTTA ATGGTGGGTTTTCTGGAGTCAAAGATGTATATTCCTCTACTCCTACACATGATGATGTACAGCAGAGCTTTTTTCTTGCTGAAACATTAA AATATTTGTATCTGCTGTTCTCCGGTGATGACCTTTTACCTTTAGACCACTGGGTGTTTAATACAGAGGCTCACCCTCTGCCTGTGTTAC ATTTAGCCAACACCACACTTTCAGGTAATCCTGCTGTTCGATGAAAGCAGTTCCAGAAGGACCATTCTCACCTGTGTTTTGTTTACATGG ACCACTACAGAAATTAGTTTGAAGGGGCGGCTTTTGAAAACCTGGACCTCTATGTCAACATGACAGGGTGAAACTATTCCCCCTAAGACT GTTCAACTTGTAGATACATCAACTTTGAAATTATTCCATTTTATACCTGACCAAAACATGTTCTGATATGTGTAGGACAGAGACCTGGAT GTGCTTTGATCGTTAATGAGGTGGTCACATGAGAAATGATACCTGTTACTACTGTATTGTTTTTAGAGTCCTGAAGTCTGGAGGCTAGAC TTCCTGAAAGCAAGTCAAGAATATAGAGCACCTTGCAGGAGTTCAAGATGGCCTTTGGAACCAATTATGTATTTGTTTCCTCCTACAGTG GAGCAGCATTCAAATCAAATATTTACATATTGCTTATCACTTTTTCTCCATTTTAATAATGGAATGAACTAAAATAAACAAGAACAAAAG AATAGTATAATTATATCAGTAACAAGAAGACTCAAAAAAGAAACAGGAGTACCTATCCCTATCTGAATTTTCAAGTTCCCCATTGGATGA CCAGACTGGCAACCATTTCAAATCCCAGTCTATTTCATTGAAATTTCTTGGTTAAGTTTAATTTTCTCTGGGGGCATGATCTCACAAAGA ATACTCAAGTCTTTTTCTTCTTATGGAATCATCGAAACTGCTATTTATCATAATCACCACTTATGAGCCTGGGTTTGGGATTTTGTGCAT GTAGTTCAGTCTAGTGTTGGTAGCATGACAGAAAGTGGGGAAAATGCCGCAGTTTGTTGCCTTGAAACCTAAGAGCAATCCTTGGTTTTG TTGCTACATTATTTTTCCAGACCAACACATCTACCAAGTAAATTTTATTCACTTTAATTTCATAATAAAGTTAGTAGAGTCACTCAACTT ACAACTTTATTTATGTGGCTTGGCAAAAATCACTATAAGGCAGCTCTAAATTTGCCTTGATAAGCTAAATAAATTACTTTTATAACTTAC TAAAGCAGAACAAACAGTGAAACTTTCTAAAATATTCTATCTGGAATAGGGACAGGGGATCTTTTATTTATAATCTCATCAGATGAGTGA GTTGTTCACAGATATTTTATGTTTTTTTAATTTTCTCCAAGAATATTTATAGAATTCCAAAGAATCAGAATAGTTTCAAAATAATTTTCA GTGATAAAAGAGTGTTGTAATTAATCATATTACACTAAAATTGGGATACATCTAAGGAACTTTATCTTACTATCAGTAGGTTTTGCATTG ATATTTCTTTTTAAATAAACTACTAGTTCTTTATATTTTGACAAAAAGAACTTAAATTTTATCAGGAACTGTAAGATAAATATCTAGTGC TTATAAATTTTCTGTCCTTAAATTTATGTGACAGTGCAAGATACTTTTGCTCTTTTCATTTAATATAGGCATCTTCCATTGACATTAATA AAACTTAGAAACAGTATAATTAGTATAACATTTACTCTGAATTTGAAGATTTCCTGAAACAAAGTTTGTACAAGAAGCCCACCTTGGAAT TCTGAAGGCTTATTTTCTTGTTTGATAAGCTTTTCTTTTAAACTTAGGTTTTAAGTTGGGGAAAGACTTAATTAACTAATATAGTATTTT CTAAGGTTGATCATCTTATACCACGAATCGTTAATTTTGACAGTTCTACTGATCCGTAAATGATAACCACTGCAAATTTTTTCAGTATAA AATTTTTCACTGCAAAAAAATTTCAGTAGAAAATAAGGATGCAGGGCCAGTTACAATAGTCCTTAAGAGAGTTAAATTATAGCACATGTT TTGACATTGTAATATCTTTTACTACTTGAACATTTAAATTTCTAAATGAGAAAGGTATATATATTACTGTAACTGTAGAAGGGAAAAGGG AAAGTATTTGGTTCTAAAAAATGTTAGCCTTCCTCGTAAAAGTAGCACAAGCCCACTTATGAATCACTGAGAAAAAGTGAAAAACTTGAG TTGGCAAAGATGCAGAGCAGCAGTGCAGATGGCAATGAACTCTCTGAATTCTCTTTTACCTTATTTAGAAGAATGCAGAGTAAAGGGACC TTCTTGGTTCTGCAGGAACTTCTCAAGGGATGAGGAGACAGAACCCCTACTTCCAAGTGCTCTATTTGTATTACCCAGATGACTGAAGCT TAAGAGAAGGCAGGGAAGTATACAAGCAGAGCCAGTTCTGGTACAAACAAAGAATTTGACAGGGACAATGGAAGGGTCTTCTTCACCACT CCTTACCTTCTATGTGATGGAAAGACTAGAGCTTATAAAAGTACTTCCATTTTTTTATTCTCCTGAATACCAAAGGCAATTAAAGTCAGC TACAAATGACTTGCCAGTGTCATGTTTTATTTTTGTTATAGATTTTTAAATTATTTCCTTCAAGATCAATTCTTATCCCATATAATGCTT AGCTTCCAAGAATATTCTTTACTTTCTTCTGTCTTTTACAGCTCTTTGCATTTTGTAGACCTTAATACTCAGGTTAAATATTCATTGCAT TTATAAGATCTTCTGCAAAAAGCCCAGAAATGGTCCTTTTCAGGTGCCTCTTCAAAGAGCTGACACCTTACCTTGTGCCTTTGGCACAAA TGTGCAGAATAGATACATCAGTTGGTGCATAATCGAAAAAAATAGGAATTTTGAACACTGTTCTTCCTTCTACATTTATTTCTCTTCATT TTAGAATCACACTTTTTATGTTAAACCAGATTATTATTATTATTATTATTCAACCAGTATTAAGTTGTTAAAACCAAGGGAATGGGGCCC TAACCAAAAAGAAGTCTCAACTCAGAAAAATAAGTCCCCAGTCAGGTGGTTCTTACTTTCTTGTGGGTTGCACATTTTGTATCTCTCTAA CATCAGCGTATTCCTGACTTTAAGCAGGTGTTTATATGTAAAATAAAACCTGGGTATCGAAGGGAAATGCATTCTTTTTATGGAGTATTG ACCCTGATCCTCTATGATGTCATATAGAGCAACTCAGGGCTATACTTGCTAGATTTTAACCAAGCAGTTTGAAATATTAATCATCATCCT CTCATCTTCTCCACTCTCCATTGCCAAAGTCTTTGTCAAAACTCCAAATTTGTTGATAAAAGATTGTGTTTGCCATTCTCATTTATAATG CAGTTTCTCCTTAAGCCTGGAGTTTTTTGAATGAGTGCATGAGTAAATGAGAGAATGTGTGAACGAACATTTATGAAGTATCTAACATGT GCCAAGCATTGTGCCTGGCACTTTCAATCATTAGAATGTTTTATGTGATTCCACAGCATTTTCTGTATGAGAGTAGCTCACAACATTTTA AATGTTTCCAATATGAATCGTGTTACAAAATTCTTAATTTTATATTTCATATAAATTAAAGAGGAAAAAGAAAAGGTTTATAATATATTT TAAAACAATGTGTTACTGTATAATACAACTATAATTGTAGTTAATAACTAAAACCTCTTGAAAATGTCAAAGAAATACTTGATTTCTGAT GCAACTTTGACTAAAATATTTACTTTAGAAATAAAAACGTTCTTATTTTGCTATATCACTTTAATTGCATAATTAAAAAGCAGTGTTTTA TAGAAATGCTGGTTATTTTATATTCAAAAAGATTTTGTCACATAATTCATGGGTAAAACTTGCAGTTGTAAATTGTGTCTGCTCTGGTAT GGGCCCTATTAATAGTCCCATGCTGTTAAATATAAAGAAAAATATACTAAAATATTCAAAGTTCCAAATAACAGTTCCTAGTAATAGTAT TTTGAGTTATTTTTCTTTAGGTTTCCTTATACTCAAATTGGCTAGGTCCTATCTTTTCCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCT CTCTCTCTATATATATATATATATATATATATATATGAGAGATATATGAGATATATGAGAGATCAAGATCTATATATGTATATAAATACA ATTATACACAGATAATTTTTAATACTCTTTGTTAACAAACACAGTTGAAAACTGGTTTCGGCTGCACAAATAAGCAGAATATTTGAGTAA CTATATATGATATGGAGATATTTTAATCCATTTATCCTGGCTCAAGAACACTGATAAAGATGATTTTCTGTTACTTTAGCTCATTCAGAT CAGGATGGACATGCTCTTTTTGATCTATAACTGTTCAGCCAGCTTCCAGATAATATTTTAGGCTATGAGAGCTATACAGTCTCTCTTATT ACTCATTTCTGCTGTTGAAGTATCGAAAACAGATAGAGATACTATGTAAAGAATGGGCGTAGCTATGTTCCAGGAAAACTTTATTTACAA AAGCAGATGGAGGGCTGGATTTGGTCCATGGGTCATAGTTAGTGACCCTGATCCCAAGTTTATTTTGTGTTAGACCCTCTAACCTTTGAT CTGCGTCTTTTCTGTTTTGATTTACATAATTCATTTTTAAATCAAAAAGATGTGCGTATATATGGTTGTGTGTATCTGTATAACCTAAAG CTATAATATTTTGTTGTCTTGAAAGCAGATACACTCTTCCTGGAGTCTGTTCAGGTTTCAGGACGATTGACTATAATGAAAGAGACAGAA TAGGGTAAGGGAAGATGGGTATGCTATCAGCCATTTTCTTTGCCTTGTCATTTAATGCCATAATTTCAGATTCTCTATGTAAAAAGAAGG TCTGTGTATTGTCAAAATAATATACTCTCCAAGTTCTCCTGCTCATTGACCCTTGAACCAGGATTCTGGATTGCTAGAGCTGCAGAAATT CACCCACTTGGGTACTCTTAGAGCTCTACAGCAAGAATATGATAGAATGTCTGATCTTTGTGCTGCAGAAAGCAAACTTTTGAAGAATTC TAAGCAACAGAAAATGGGTTATGTGACTCATCTGCTATTTGGCAGCCACTATTCCTTTTTTAGACTGCAGAACGGTACTGCCCCTGTTAC CTCTAGAATAGCCTGAGTCTGAGGAGTGCAGAGAAAAGATATATCCAAAAGGAGAATCCCTTTCTCTTGCATAACTCTCAATCCTTTACA AGTAAGTAGCATTATTTCAGAATGTCTATATGCATCATTTTCAACTAAAGCATACCTCATCCTTAAACTTCCACTATTTAACAGCTAATC CATTTCAAACTTGGTTTGAGCCTAGCAATTGCAGAACTCATAAAATTGCTTGTGAAATTACACACCATATTACTAGCATATACATTGCAG TGCTCCAATCATGCTAACAGATAATAGATTTTTCTTTAAGAATTTTATCAAATATTTCACTATTTGGGGAAATTTTAGAGGAGGGGAAGC CTGTATTCAGGATGATAGAGGGAGCAGAGACTTACTGTCTCTCTTCCACATTATAAATGAACTGCCTTTCCAGGTCCAACATGCTGTCAG GTTGCTTCAGCTCGGTGTGAATGTAAGTGTGGGGATCAAACACACACACCTATACACATACATATTAATATGCAGAGGATTTTAAATAAT TGCAAATGTCTTGTGGCTGTTTTATTTCTACAAAATTCTGTAAGATGTATACCAGAAAACATAATAAAGATAAGCTCAGTTCTTCATTGG GAAAAAATATTTTTAAAGAAAATTTAGAAGTTTTTGCTGAATTAAAGTATCTTCAATTTTAATTACTGGATTTGGAAGTTGAAATGCCAT CCTTCAATATCACTGGTCTCAAATTCATTGATAGAATTTTTTCTTAAACTAATAAGTGGGGTAAGTATAATCTCCTAAATTGGTACCCAC TGGCTGCTCCTAAACTGGTTTCCAGTCATGTCCTCCAGTATGTGATTTTTATAAATTAAAGGTAATATTGTATATTAAAGTTCAAATAAA >73447_73447_2_REL-MAN1A2_REL_chr2_61147777_ENST00000394479_MAN1A2_chr1_118035769_ENST00000356554_length(amino acids)=604AA_BP=352 MTAAASGQDAGSCLREGAGSGAMASGAYNPYIEIIEQPRQRGMRFRYKCEGRSAGSIPGEHSTDNNRTYPSIQIMNYYGKGKVRITLVTK NDPYKPHPHDLVGKDCRDGYYEAEFGQERRPLFFQNLGIRCVKKKEVKEAIITRIKAGINPFNVPEKQLNDIEDCDLNVVRLCFQVFLPD EHGNLTTALPPVVSNPIYDNRAPNTAELRICRVNKNCGSVRGGDEIFLLCDKVQKDDIEVRFVLNDWEAKGIFSQADVHRQVAIVFKTPP YCKAITEPVTVKMQLRRPSDQEVSESMDFRYLPDEKDTYGNKAKKQKTTLLFQKLCQDHVNFPERPRPGLLGSIGEGRYFKKDHTSVGGL GDSFYEYLLKAWLMSDKTDHEARKMYDDAIEAIEKHLIKKSRGGLTFIGEWKNGHLEKKMGHLACFAGGMFALGADGSRADKAGHYLELG AEIARTCHESYDRTALKLGPESFKFDGAVEAVAVRQAEKYYILRPEVIETYWYLWRFTHDPRYRQWGWEAALAIEKYCRVNGGFSGVKDV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for REL-MAN1A2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for REL-MAN1A2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for REL-MAN1A2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | REL | C0003873 | Rheumatoid Arthritis | 3 | CTD_human |
Hgene | REL | C0019829 | Hodgkin Disease | 1 | CGI;CTD_human |
Hgene | REL | C0025261 | Memory Disorders | 1 | CTD_human |
Hgene | REL | C0030246 | Pustulosis of Palms and Soles | 1 | CTD_human |
Hgene | REL | C0033860 | Psoriasis | 1 | CTD_human |
Hgene | REL | C0152266 | Mixed Cellularity Hodgkin Lymphoma | 1 | CTD_human |
Hgene | REL | C0152267 | Hodgkin lymphoma, lymphocyte depletion | 1 | CTD_human |
Hgene | REL | C0220597 | Adult Hodgkin Lymphoma | 1 | CTD_human |
Hgene | REL | C0233794 | Memory impairment | 1 | CTD_human |
Hgene | REL | C0751292 | Age-Related Memory Disorders | 1 | CTD_human |
Hgene | REL | C0751293 | Memory Disorder, Semantic | 1 | CTD_human |
Hgene | REL | C0751294 | Memory Disorder, Spatial | 1 | CTD_human |
Hgene | REL | C0751295 | Memory Loss | 1 | CTD_human |
Hgene | REL | C1266194 | Lymphocyte Rich Classical Hodgkin Lymphoma | 1 | CTD_human |
Hgene | REL | C1334968 | Nodular Lymphocyte Predominant Hodgkin Lymphoma | 1 | CTD_human |